{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:41:50Z","timestamp":1794444110398,"version":"4.9.1"},"publisher-location":"Berlin, Heidelberg","reference-count":17,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540610243","type":"print"},{"value":"9783662008188","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1996]]},"DOI":"10.1007\/978-3-662-00818-8_36","type":"book-chapter","created":{"date-parts":[[2013,4,14]],"date-time":"2013-04-14T23:28:22Z","timestamp":1365982102000},"page":"144-150","source":"Crossref","is-referenced-by-count":0,"title":["Two-year data from the European multicentre tacrolimus (FK 506) liver study"],"prefix":"10.1007","author":[{"given":"Roger","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Bismuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"McMaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Pichlmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Calne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Groth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"36_CR1","first-page":"45","volume":"27","author":"Bismuth H for the European FK506 multicenter liver study group","year":"1995","unstructured":"Bismuth H for the European FK506 multicenter liver study group (1995) Comparison of FK 506- and cyclosporine-based immunosuppression: FK506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. Transplant Proc 27: 45 - 49","journal-title":"Transplant Proc"},{"issue":"1","key":"36_CR2","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1111\/j.1432-2277.1994.tb01300.x","volume":"7","author":"H Bismuth","year":"1994","unstructured":"Bismuth H, Samuel D, Neuhaus P, McMaster P, Calne R, Pichlmayr R, Otto G, Williams R, Groth C (1994) Focus on intractable rejection: 6-month results of the European multicentre study of FK 506 and cyclosporin A. Transplant Int 7 [Suppl 1]: S3 \u2014 S6","journal-title":"Transplant Int"},{"key":"36_CR3","first-page":"3175","volume":"26","author":"W Christe","year":"1994","unstructured":"Christe W (1994) Neurological disorders in liver and kidney transplant recipients. Transplant Proc 26: 3175 - 3176","journal-title":"Transplant Proc"},{"key":"36_CR4","unstructured":"Devlin J, Williams R, Neuhaus P, McMaster P, Calne R, Pichlmayr R, Otto G, Bismuth H, Groth C (1994) Renal complications and development of hypertension in the European study of FK506 and cyclosporin in primary liver transplant recipients. Transplant Int 7 [Suppl 1]: S22\u2014S26 S 150"},{"issue":"1","key":"36_CR5","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1111\/j.1432-2277.1994.tb01302.x","volume":"7","author":"B Ericzon","year":"1994","unstructured":"Ericzon B, Groth C, Bismuth H, Caine 9. R, McMaster P, Neuhaus P, Otto G, Pichlmayr R, Williams R (1994) Glu-cose metabolism in liver transplant recipients treated with FK 506 or cy- 10. closporin in the European multicentre study. Transplant Int 7 [Suppl 1]: S11 \u2014 S14","journal-title":"Transplant Int"},{"key":"36_CR6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0140-6736(94)91766-3","volume":"344","author":"European FK506 multicentre liver study group","year":"1994","unstructured":"European FK506 multicentre liver study group (1994) Randomised trial 11. comparing tacrolimus (FK 506) and cyclosporin in prevention of liver allograft rejection. Lancet 344: 423 - 428","journal-title":"Lancet"},{"issue":"12","key":"36_CR7","first-page":"3270","volume":"26","author":"U Frei","year":"1994","unstructured":"Frei U, Wagner K (1994) Renal function in liver transplant patients receiving FK506 or cyclosporin A immunosuppressive therapy. Transplant Proc 26: 12. 3270 - 3271","journal-title":"Transplant Proc"},{"key":"36_CR8","first-page":"2977","volume":"23","author":"J Fung","year":"1991","unstructured":"Fung J, Abu-Elmagd K, Jain A, Gordon R, Tzakis A, Todo S, Takaya S, Ales- siani M, Demetris A, Bronster O, Martin M, Mieles L, Selby R, Reyes J, Doyle H, Stieber A, Casavilla A, Starzl T (1991) A randomized trial of primary liver transplantation under immuno- 13. suppression with FK 506 vs cyclosporine. Transplant Proc 23: 2977 - 2983","journal-title":"Transplant Proc"},{"key":"36_CR9","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1111\/j.1432-2277.1994.tb01306.x","volume":"11","author":"P McMaster","year":"1994","unstructured":"McMaster P (1994) Patient and graft survival in the European multicentre liver study \u2014 FK 506 vs cyclosporin A. Transplant Int 7 [Suppl] 11: S32 \u2014 S36","journal-title":"Transplant Int 7 [Suppl]"},{"key":"36_CR10","first-page":"3264","volume":"26","author":"PJ Neuhaus","year":"1994","unstructured":"Neuhaus PJ (1994) Optimised first-line FK506-based protocol in liver transplantation: experience from the University Hospital Rudolf Virchow, Berlin. Transplant Proc 26: 3264 - 3266","journal-title":"Transplant Proc"},{"issue":"11","key":"36_CR11","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1111\/j.1432-2277.1994.tb01305.x","volume":"7","author":"P Neuhaus","year":"1994","unstructured":"Neuhaus P, McMaster P, Caine R, Pichlmayr R, Otto G, Williams R, Bismuth H, Groth C (1994) Neurological complications in the European multi-centre study of FK 506 and cyclosporin in primary liver transplantation. Transplant Int 7 [Supp11]: S27 \u2014 S31","journal-title":"Transplant Int"},{"key":"36_CR12","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1111\/j.1432-2277.1994.tb01301.x","volume":"11","author":"G Otto","year":"1994","unstructured":"Otto G, Bleyl J, Neuhaus P, McMaster P, Caine R, Pichlmayr R, Williams R, Bismuth H, Groth C (1994) Corticosteroids and concomitant medication in the European multicentre study of FK 506 and cyclosporin I primary liver transplantation. Transplant Int 7 [Sup-pl 11: S7 \u2014 S10","journal-title":"Transplant Int 7 [Sup-pl"},{"key":"36_CR13","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/S0140-6736(95)92349-7","volume":"346","author":"TE Starzl","year":"1995","unstructured":"Starzl TE, Donner A, Eliasziw M, Stitt L, Meier P, Fung JJ, McMichael JP, Todo S (1995) Randomized trialomania? The multicenter liver transplant trials. Lancet 346: 1346 - 1350","journal-title":"Lancet"},{"key":"36_CR14","first-page":"3260","volume":"26","author":"The European FK506 multicentre liver study group","year":"1994","unstructured":"The European FK506 multicentre liver study group (1994) Reduced incidence of acute, refractory acute, and chronic rejection after liver transplantation with FK 506-based immunosuppression. Transplant Proc 26: 3260 - 3263","journal-title":"Transplant Proc"},{"key":"36_CR15","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1056\/NEJM199410273311702","volume":"331","author":"The U.S. multicenter FK 506 liver study group","year":"1994","unstructured":"The U.S. multicenter FK 506 liver study group (1994) A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 331: 1110 - 1115","journal-title":"N Engl J Med"},{"key":"36_CR16","first-page":"1397","volume":"23","author":"S Todo","year":"1991","unstructured":"Todo S, Fung JJ, Tzakis A, Demetris AJ, Jain A, Alessiani M, Takaya S, Day R, Gordon R, Starzl TE (1991) One hun- dred ten consecutive primary ortho- topic liver transplants under FK506 in adults. Transplant Proc 23: 1397 - 1402","journal-title":"Transplant Proc"},{"issue":"1","key":"36_CR17","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1111\/j.1432-2277.1994.tb01311.x","volume":"7","author":"M Winkler","year":"1994","unstructured":"Winkler M, Pichlmayr R, Neuhaus P, McMaster P, Caine R, Otto G, Williams R, Bismuth H, Groth C (1994) Optimal FK506 dosage in patients under primary immunosuppression following liver transplantation. Transplant Int 7 [Suppl 1]: S58 \u2014 S63","journal-title":"Transplant Int"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-662-00818-8_36","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T05:36:33Z","timestamp":1557639393000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-662-00818-8_36"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996]]},"ISBN":["9783540610243","9783662008188"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-3-662-00818-8_36","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-662-00818-8","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[1996]]}}}